DK2963006T3 - COMPOSITION CONTAINING ALPHA-TOCOTRIENOLQUINON AND SUBSTANCES THEREOF - Google Patents
COMPOSITION CONTAINING ALPHA-TOCOTRIENOLQUINON AND SUBSTANCES THEREOF Download PDFInfo
- Publication number
- DK2963006T3 DK2963006T3 DK15175938.8T DK15175938T DK2963006T3 DK 2963006 T3 DK2963006 T3 DK 2963006T3 DK 15175938 T DK15175938 T DK 15175938T DK 2963006 T3 DK2963006 T3 DK 2963006T3
- Authority
- DK
- Denmark
- Prior art keywords
- alpha
- less
- tocotrienol
- purity
- tetramethylhexadeca
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C46/00—Preparation of quinones
- C07C46/02—Preparation of quinones by oxidation giving rise to quinoid structures
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C46/00—Preparation of quinones
- C07C46/02—Preparation of quinones by oxidation giving rise to quinoid structures
- C07C46/06—Preparation of quinones by oxidation giving rise to quinoid structures of at least one hydroxy group on a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19758508P | 2008-10-28 | 2008-10-28 | |
EP09824070.8A EP2362875B1 (en) | 2008-10-28 | 2009-10-27 | Process for the production of alpha-tocotrienol and derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2963006T3 true DK2963006T3 (en) | 2019-01-14 |
Family
ID=42118126
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15175938.8T DK2963006T3 (en) | 2008-10-28 | 2009-10-27 | COMPOSITION CONTAINING ALPHA-TOCOTRIENOLQUINON AND SUBSTANCES THEREOF |
DK09824070.8T DK2362875T3 (en) | 2008-10-28 | 2009-10-27 | METHOD OF PRODUCING ALPHA-tocotrienol AND DERIVATIVES |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09824070.8T DK2362875T3 (en) | 2008-10-28 | 2009-10-27 | METHOD OF PRODUCING ALPHA-tocotrienol AND DERIVATIVES |
Country Status (18)
Country | Link |
---|---|
US (6) | US8106223B2 (zh) |
EP (3) | EP2963006B1 (zh) |
JP (7) | JP5775459B2 (zh) |
CN (2) | CN102264730B (zh) |
BR (1) | BRPI0920414B1 (zh) |
CA (2) | CA2741767C (zh) |
DK (2) | DK2963006T3 (zh) |
EA (2) | EA026417B1 (zh) |
ES (2) | ES2701260T3 (zh) |
HK (2) | HK1161876A1 (zh) |
HU (1) | HUE041714T2 (zh) |
MX (1) | MX2011004440A (zh) |
MY (2) | MY185183A (zh) |
PL (2) | PL2963006T3 (zh) |
PT (2) | PT2362875E (zh) |
SI (1) | SI2963006T1 (zh) |
TR (1) | TR201819154T4 (zh) |
WO (1) | WO2010051277A1 (zh) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7514461B2 (en) | 2003-09-19 | 2009-04-07 | Edison Pharmaceuticals, Inc. | Chroman derivatives |
EA016226B1 (ru) | 2005-06-01 | 2012-03-30 | Эдисон Фармасьютикалз, Инк. | Редокс-активные терапевтические соединения для лечения митохондриальных заболеваний |
EP1986636B1 (en) | 2006-02-22 | 2013-04-24 | Edison Pharmaceuticals, Inc. | Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases |
DK2220030T3 (en) | 2007-11-06 | 2016-04-11 | Edison Pharmaceuticals Inc | 4- (P-QUINONYL) -2-HYDROXYBUTANAMIDDERIVATER TO TREAT mitochondrial |
CA2708961C (en) * | 2008-01-08 | 2017-03-28 | Edison Pharmaceuticals, Inc. | (het)aryl-p-quinone derivatives for treatment of mitochondrial diseases |
WO2009111576A2 (en) | 2008-03-05 | 2009-09-11 | Edison Pharmaceuticals, Inc. | 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES |
US8716486B2 (en) * | 2008-06-25 | 2014-05-06 | Edison Pharmaceuticals, Inc. | 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
JP2012502064A (ja) | 2008-09-10 | 2012-01-26 | エジソン ファーマシューティカルズ, インコーポレイテッド | 酸化還元活性治療剤を用いての広汎性発達障害の処置 |
EP2362726B1 (en) | 2008-10-14 | 2018-08-08 | Bioelectron Technology Corporation | Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells |
SI2963006T1 (sl) * | 2008-10-28 | 2019-01-31 | Bioelectron Technology Corporation | Sestavek vsebujoč alfa-tokotrienol kinon in njegove vmesne povezave |
ES2662051T3 (es) | 2009-04-28 | 2018-04-05 | Bioelectron Technology Corporation | Tratamiento de neuropatía óptica hereditaria de Leber y atrofia óptica dominante con tocotrienol quinonas |
ES2663709T3 (es) * | 2009-08-26 | 2018-04-16 | Bioelectron Technology Corporation | Métodos para la prevención y el tratamiento de la isquemia cerebral |
WO2012154613A1 (en) * | 2011-05-06 | 2012-11-15 | Edison Pharmaceuticals, Inc. | Improved process for the preparation of d-alpha-tocotrienol from natural extracts |
WO2012174286A1 (en) | 2011-06-14 | 2012-12-20 | Edison Pharmaceuticals, Inc. | Catechol derivatives for treatment of oxidative stress diseases |
CA2842486C (en) | 2011-07-19 | 2022-09-06 | Edison Pharmaceuticals, Inc. | Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols |
MY162508A (en) * | 2011-07-21 | 2017-06-15 | Sime Darby Malaysia Berhad | External preparation for skin |
JP6393684B2 (ja) | 2012-09-07 | 2018-09-19 | バイオエレクトロン テクノロジー コーポレイション | 個体のレドックス状態の調節において使用するためのキノン誘導体 |
US8937191B2 (en) | 2012-12-20 | 2015-01-20 | Orochem Technologies, Inc. | Recovery of highly pure alpha-tocotrienol from crude palm oil extract |
US9296712B2 (en) | 2013-03-15 | 2016-03-29 | Edison Pharmaceuticals, Inc. | Resorufin derivatives for treatment of oxidative stress disorders |
WO2014145116A2 (en) | 2013-03-15 | 2014-09-18 | Edison Pharmaceuticals, Inc. | Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders |
US9670170B2 (en) | 2013-03-15 | 2017-06-06 | Bioelectron Technology Corporation | Resorufin derivatives for treatment of oxidative stress disorders |
US9868711B2 (en) | 2013-03-15 | 2018-01-16 | Bioelectron Technology Corporation | Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders |
EP3074460A1 (en) * | 2013-11-29 | 2016-10-05 | Saudi Basic Industries Corporation | Stabilised polyolefin composition |
US9512098B1 (en) | 2014-02-03 | 2016-12-06 | Board Of Trustees Of The University Of Arkansas | Process of producing purified gamma- and delta-tocotrienols from tocol-rich oils or distillates |
CN104262315A (zh) * | 2014-09-05 | 2015-01-07 | 宁波大红鹰生物工程股份有限公司 | 一种生育三烯酚的分离提纯方法 |
JP6810692B2 (ja) | 2014-12-16 | 2021-01-06 | ピーティーシー セラピューティクス, インコーポレイテッド | (r)−2−ヒドロキシ−2−メチル−4−(2,4,5−トリメチル−3,6−ジオキソシクロヘキサ−1,4−ジエニル)ブタンアミドの多形性形態および非晶質形態 |
WO2016114860A1 (en) | 2015-01-12 | 2016-07-21 | Edison Pharmaceuticals, Inc. | Quinones for protection against radiation exposure |
WO2017106786A1 (en) * | 2015-12-16 | 2017-06-22 | Bioelectron Technology Corporation | Improved methods for enriching alpha-tocotrienol from mixed tocol compositions |
WO2017106803A1 (en) | 2015-12-17 | 2017-06-22 | Bioelectron Technology Corporation | Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
CA3011293A1 (en) | 2016-01-12 | 2017-07-20 | Bioelectron Technology Corporation | Tocopherol and tocotrienol quinone derivatives for increasing thiosulfate levels or decreasing hydrogen sulfide levels |
JP2018083799A (ja) | 2016-11-15 | 2018-05-31 | バイオエレクトロン テクノロジー コーポレイション | 2−置換アミノ−ナフト[1,2−d]イミダゾール−5−オン化合物またはその製薬学上許容される塩 |
US20200121618A1 (en) | 2017-04-14 | 2020-04-23 | Bioelectron Technology Corporation | Methods and compositions for treatment of inflammation and oxidative stress |
PL3866772T3 (pl) | 2018-10-17 | 2024-04-08 | Ptc Therapeutics, Inc. | 2,3,5-trimetylo-6-nonylocykloheksa-2,5-dieno-1,4-dion do hamowania i leczenia alfa-synukleinopatii, tauopatii i innych zaburzeń |
KR20220078644A (ko) | 2019-10-04 | 2022-06-10 | 스텔스 바이오테라퓨틱스 인코포레이티드 | 미토콘드리아 질환 치료를 위한 바티퀴논의 퀴논-, 히드로퀴논- 및 나프토퀴논-유사체 |
WO2023283466A1 (en) | 2021-07-08 | 2023-01-12 | Ptc Therapeutics, Inc. | Pharmaceutical compositions comprising 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione |
Family Cites Families (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2519863A (en) * | 1949-05-14 | 1950-08-22 | Eastman Kodak Co | Conversion of beta-, gamma-, and delta-tocopherol to alpha-tocopherol by aminoalkylation and reduction |
US4977282A (en) * | 1984-04-17 | 1990-12-11 | Henkel Corporation | Production of d-alpha-tocopherol from natural plant sources |
EP0159018A3 (en) * | 1984-04-17 | 1986-10-01 | HENKEL CORPORATION (a Delaware corp.) | Production of d-alpha-tocopherol from natural plant sources |
US4603142A (en) | 1984-06-01 | 1986-07-29 | Wisconsin Alumni Research Foundation | Cholesterol lowering method of use |
JPS636186A (ja) | 1986-06-23 | 1988-01-12 | タツタ電線株式会社 | 点滴監視装置 |
JPH0788376B2 (ja) | 1986-09-02 | 1995-09-27 | エーザイ株式会社 | 光学活性α−トコトリエノ−ルの製造方法 |
JP2685785B2 (ja) | 1988-03-11 | 1997-12-03 | エーザイ株式会社 | 光学活性α−トコトリエノールの製造方法 |
EP0333472B1 (en) | 1988-03-16 | 1997-10-08 | PALM OIL RESEARCH & DEVELOPMENT BOARD | Production of high concentration tocopherols and tocotrienols from palm oil by-products |
US5157132A (en) | 1990-05-18 | 1992-10-20 | Carotech Associates | Integrated process for recovery of carotenoids and tocotrienols from oil |
WO1993009777A1 (en) * | 1991-11-22 | 1993-05-27 | Lipogenics, Inc. | Tocotrienols and tocotrienol-like compounds and methods for their use |
ES2148616T3 (es) * | 1995-03-28 | 2000-10-16 | Hoffmann La Roche | Aminometilacion de los tocoferoles. |
US5660691A (en) * | 1995-11-13 | 1997-08-26 | Eastman Chemical Company | Process for the production of tocotrienol/tocopherol blend concentrates |
US6232060B1 (en) | 1996-01-19 | 2001-05-15 | Galileo Laboratories, Inc. | Assay system for anti-stress agents |
US5801159A (en) | 1996-02-23 | 1998-09-01 | Galileo Laboratories, Inc. | Method and composition for inhibiting cellular irreversible changes due to stress |
US5932748A (en) * | 1997-06-06 | 1999-08-03 | Roche Vitamins Inc. | Process for permethylating non-α-tocopherols to produce α-tocopherol |
CN1137077C (zh) * | 1997-10-29 | 2004-02-04 | 弗莱克斯塞思美国有限合伙公司 | 使用过氧化氢和催化剂由苯二胺制备醌二亚胺的方法 |
JP2002501916A (ja) * | 1998-01-29 | 2002-01-22 | イーストマン ケミカル カンパニー | トコール含有混合物からのトコトリエノールの分離方法及びその組成物 |
EP1044687B1 (en) * | 1998-11-06 | 2008-09-03 | Fuji Chemical Industry Co., Ltd. | Powders containing tocotrienols and tablets prepared by compression molding the same |
US6395915B1 (en) | 1999-09-10 | 2002-05-28 | Technikrom, Inc. | Method for producing purified tocotrienols and tocopherols using liquid chromatography |
MY127451A (en) * | 1999-11-04 | 2006-12-29 | Malaysian Palm Oil Board | A method of chromatographic isolation for vitamin e isomers |
DE10034233A1 (de) * | 2000-07-14 | 2002-01-24 | Basf Ag | Tocotrienolchinon-Cyclisierungsprodukte |
US7034054B2 (en) | 2000-12-15 | 2006-04-25 | Galileo Pharmaceuticals, Inc. | Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols |
US6838104B2 (en) | 2000-12-20 | 2005-01-04 | Archer Daniels Midland Company | Process for the production of tocotrienols |
US6608196B2 (en) | 2001-05-03 | 2003-08-19 | Galileo Pharmaceuticals, Inc. | Process for solid supported synthesis of pyruvate-derived compounds |
JP4842455B2 (ja) | 2001-06-13 | 2011-12-21 | コマツNtc株式会社 | 半導体単結晶引上げ装置及びそのライン構成 |
JP2003171376A (ja) | 2001-09-27 | 2003-06-20 | Lion Corp | トコフェロール類及びトコトリエノール類濃縮物、その製造方法 |
US6667330B2 (en) | 2002-01-31 | 2003-12-23 | Galileo Pharmaceuticals, Inc. | Furanone derivatives |
US6653346B1 (en) | 2002-02-07 | 2003-11-25 | Galileo Pharmaceuticals, Inc. | Cytoprotective benzofuran derivatives |
US6590113B1 (en) * | 2002-03-26 | 2003-07-08 | Ronald T. Sleeter | Process for treating oils containing antioxidant compounds |
CA2504334A1 (en) | 2002-10-30 | 2004-05-21 | Galileo Pharmaceuticals, Inc. | Identifying therapeutic compounds based on their physical-chemical properties |
MY130618A (en) | 2002-11-27 | 2007-07-31 | Malaysian Palm Oil Board | A method of extracting and isolating minor components from vegetable oil |
US7514461B2 (en) | 2003-09-19 | 2009-04-07 | Edison Pharmaceuticals, Inc. | Chroman derivatives |
WO2005035490A2 (en) * | 2003-10-10 | 2005-04-21 | Yasoo Health, Inc. | PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS |
MY173044A (en) * | 2003-11-19 | 2019-12-20 | Carotech Bhd | Recovery of phytonutriens from oils |
US7393662B2 (en) | 2004-09-03 | 2008-07-01 | Centocor, Inc. | Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
EA016226B1 (ru) | 2005-06-01 | 2012-03-30 | Эдисон Фармасьютикалз, Инк. | Редокс-активные терапевтические соединения для лечения митохондриальных заболеваний |
ES2823728T3 (es) | 2005-09-15 | 2021-05-10 | Ptc Therapeutics Inc | Variantes de cola de agentes terapéuticos con actividad redox para el tratamiento de enfermedades mitocondriales y otras afecciones y la modulación de biomarcadores de energía |
EP1986636B1 (en) | 2006-02-22 | 2013-04-24 | Edison Pharmaceuticals, Inc. | Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases |
WO2007105297A1 (ja) * | 2006-03-13 | 2007-09-20 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | メチン系色素とその用途 |
AU2008205263A1 (en) | 2007-01-10 | 2008-07-17 | Edison Pharmaceuticals, Inc. | Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity |
MY162051A (en) | 2007-05-24 | 2017-05-31 | Loders Croklaan Bv | Process for producing compositions comprising tocopherols and tocotrienols |
DK2220030T3 (en) | 2007-11-06 | 2016-04-11 | Edison Pharmaceuticals Inc | 4- (P-QUINONYL) -2-HYDROXYBUTANAMIDDERIVATER TO TREAT mitochondrial |
EP2242506A4 (en) | 2008-01-07 | 2011-12-28 | Janssen Biotech Inc | METHOD FOR THE TREATMENT OF ERYTHROPOIETIN HYPORESPONSE ANIMALS |
CA2708961C (en) | 2008-01-08 | 2017-03-28 | Edison Pharmaceuticals, Inc. | (het)aryl-p-quinone derivatives for treatment of mitochondrial diseases |
US20110046156A1 (en) * | 2008-03-05 | 2011-02-24 | Miller Guy M | Treatment of hearing and balance impairments with redox-active therapeutics |
WO2009111576A2 (en) | 2008-03-05 | 2009-09-11 | Edison Pharmaceuticals, Inc. | 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES |
CA2723621A1 (en) | 2008-05-15 | 2009-11-19 | Edison Pharmaceuticals, Inc | Treatment of hearing and balance impairments using compounds having erythropoietin activity |
EA201001814A1 (ru) | 2008-05-22 | 2011-04-29 | Эдисон Фармасьютикалз, Инк. | Лечение митохондриальных заболеваний миметиками эритропоэтина |
US8716486B2 (en) | 2008-06-25 | 2014-05-06 | Edison Pharmaceuticals, Inc. | 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
WO2010005989A1 (en) | 2008-07-09 | 2010-01-14 | Edison Pharmaceuticals, Inc. | Dermatological compositions with anti-aging and skin even-toning properties |
US20100029784A1 (en) | 2008-07-30 | 2010-02-04 | Hinman Andrew W | Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties |
US20100029706A1 (en) | 2008-07-30 | 2010-02-04 | Edison Parmaceuticals, Inc. a Delaware Corporation | HYDROGENATED PYRIDO[4,3-b]INDOLES FOR THE TREATMENT OF OXIDATIVE STRESS |
JP2012502064A (ja) * | 2008-09-10 | 2012-01-26 | エジソン ファーマシューティカルズ, インコーポレイテッド | 酸化還元活性治療剤を用いての広汎性発達障害の処置 |
EP2362726B1 (en) | 2008-10-14 | 2018-08-08 | Bioelectron Technology Corporation | Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells |
SI2963006T1 (sl) * | 2008-10-28 | 2019-01-31 | Bioelectron Technology Corporation | Sestavek vsebujoč alfa-tokotrienol kinon in njegove vmesne povezave |
ES2662051T3 (es) | 2009-04-28 | 2018-04-05 | Bioelectron Technology Corporation | Tratamiento de neuropatía óptica hereditaria de Leber y atrofia óptica dominante con tocotrienol quinonas |
WO2010126909A1 (en) | 2009-04-28 | 2010-11-04 | Edison Pharmaceuticals, Inc. | Formulation of tocotrienol quinones for the treatment of ophthalmic diseases |
CA2760357A1 (en) | 2009-04-28 | 2010-11-04 | Ampere Life Sciences, Inc. | Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseases |
MX2011013558A (es) | 2009-06-25 | 2012-04-30 | Ampere Life Sciences Inc | Tratamiento del trastorno pervasivo del desarrollo con tocotrienoles o extractos de tocotrienoles enriquecidos. |
ES2663709T3 (es) | 2009-08-26 | 2018-04-16 | Bioelectron Technology Corporation | Métodos para la prevención y el tratamiento de la isquemia cerebral |
WO2011082355A1 (en) | 2009-12-31 | 2011-07-07 | Edison Pharmaceuticals, Inc. | Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones |
EA201201268A1 (ru) | 2010-03-09 | 2013-04-30 | Эдисон Фармасьютикалз, Инк. | Синтез производных альфа-токоферолхинона и способы их применения |
WO2011113018A1 (en) | 2010-03-12 | 2011-09-15 | Ampere Life Sciences, Inc. | Measurement and control of biological time |
CA2795726A1 (en) | 2010-04-06 | 2011-10-13 | Edison Pharmaceuticals, Inc. | Treatment of ataxia telangiectasia |
WO2011137126A1 (en) | 2010-04-27 | 2011-11-03 | Edison Pharmaceuticals, Inc. | Formulations of quinones for the treatment of ophthalmic diseases |
WO2012009271A1 (en) | 2010-07-14 | 2012-01-19 | Penwest Pharmaceuticals Co. | Methods of providing anticoagulation effects in subjects |
CA2807507A1 (en) | 2010-08-06 | 2012-02-09 | Edison Pharmaceuticals, Inc. | Treatment of mitochondrial diseases with naphthoquinones |
US20120295985A1 (en) | 2010-11-19 | 2012-11-22 | Miller Guy M | Methods for improving blood glucose control |
WO2012154613A1 (en) | 2011-05-06 | 2012-11-15 | Edison Pharmaceuticals, Inc. | Improved process for the preparation of d-alpha-tocotrienol from natural extracts |
WO2012170773A1 (en) | 2011-06-08 | 2012-12-13 | Edison Pharmaceuticals, Inc. | Adjunctive therapy for the treatment of mitochondrial disorders with quinones and naphthoquinones |
WO2012174286A1 (en) | 2011-06-14 | 2012-12-20 | Edison Pharmaceuticals, Inc. | Catechol derivatives for treatment of oxidative stress diseases |
WO2013006736A1 (en) | 2011-07-06 | 2013-01-10 | Edison Pharmaceuticals, Inc | Treatment of leigh syndrome and leigh-like syndrome, including complications of sucla2 mutations, with tocotrienol quinones |
EP2729004B1 (en) | 2011-07-06 | 2020-03-25 | PTC Therapeutics, Inc. | Treatment of methylmalonic aciduria, isovaleric aciduria, and other organic acidurias with tocotrienol quinones |
CA2842486C (en) | 2011-07-19 | 2022-09-06 | Edison Pharmaceuticals, Inc. | Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols |
JP6393684B2 (ja) | 2012-09-07 | 2018-09-19 | バイオエレクトロン テクノロジー コーポレイション | 個体のレドックス状態の調節において使用するためのキノン誘導体 |
US8937191B2 (en) | 2012-12-20 | 2015-01-20 | Orochem Technologies, Inc. | Recovery of highly pure alpha-tocotrienol from crude palm oil extract |
MX355430B (es) | 2013-03-08 | 2018-04-18 | Unilever Nv | Compuestos de resorcinol para uso dermatologico. |
WO2014145116A2 (en) | 2013-03-15 | 2014-09-18 | Edison Pharmaceuticals, Inc. | Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders |
US9868711B2 (en) | 2013-03-15 | 2018-01-16 | Bioelectron Technology Corporation | Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders |
US20140275045A1 (en) | 2013-03-15 | 2014-09-18 | Edison Pharmaceuticals, Inc. | Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders |
US9296712B2 (en) | 2013-03-15 | 2016-03-29 | Edison Pharmaceuticals, Inc. | Resorufin derivatives for treatment of oxidative stress disorders |
US9670170B2 (en) | 2013-03-15 | 2017-06-06 | Bioelectron Technology Corporation | Resorufin derivatives for treatment of oxidative stress disorders |
EP3004071A1 (en) | 2013-05-31 | 2016-04-13 | Edison Pharmaceuticals, Inc. | Carboxylic acid derivatives for treatment of oxidative stress disorders |
EP3233819A1 (en) | 2014-12-16 | 2017-10-25 | Bioelectron Technology Corporation | Methods for chiral resolution of trolox |
JP6810692B2 (ja) | 2014-12-16 | 2021-01-06 | ピーティーシー セラピューティクス, インコーポレイテッド | (r)−2−ヒドロキシ−2−メチル−4−(2,4,5−トリメチル−3,6−ジオキソシクロヘキサ−1,4−ジエニル)ブタンアミドの多形性形態および非晶質形態 |
WO2016114860A1 (en) | 2015-01-12 | 2016-07-21 | Edison Pharmaceuticals, Inc. | Quinones for protection against radiation exposure |
WO2017106786A1 (en) | 2015-12-16 | 2017-06-22 | Bioelectron Technology Corporation | Improved methods for enriching alpha-tocotrienol from mixed tocol compositions |
WO2017106803A1 (en) | 2015-12-17 | 2017-06-22 | Bioelectron Technology Corporation | Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
WO2017123823A1 (en) | 2016-01-12 | 2017-07-20 | Bioelectron Technology Corporation | Alkyl-, acyl-, urea-, and aza-uracil sulfide:quinone oxidoreductase inhibitors |
CA3011293A1 (en) | 2016-01-12 | 2017-07-20 | Bioelectron Technology Corporation | Tocopherol and tocotrienol quinone derivatives for increasing thiosulfate levels or decreasing hydrogen sulfide levels |
US20190241497A1 (en) | 2016-10-28 | 2019-08-08 | Andrew W. Hinman | Methods for analyzing p-hydroquinone levels and ratios |
WO2018093957A1 (en) | 2016-11-15 | 2018-05-24 | Bioelectron Technology Corporation | 2-substituted amino-naphth[1,2-d]imidazol-5-one compounds or pharmaceutically acceptable salts thereof cross reference to related applications |
WO2018129411A1 (en) | 2017-01-06 | 2018-07-12 | Bioelectron Technology Corporation | Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders |
US20200121618A1 (en) | 2017-04-14 | 2020-04-23 | Bioelectron Technology Corporation | Methods and compositions for treatment of inflammation and oxidative stress |
-
2009
- 2009-10-27 SI SI200931894T patent/SI2963006T1/sl unknown
- 2009-10-27 PL PL15175938T patent/PL2963006T3/pl unknown
- 2009-10-27 DK DK15175938.8T patent/DK2963006T3/en active
- 2009-10-27 CN CN200980152635.0A patent/CN102264730B/zh active Active
- 2009-10-27 CA CA2741767A patent/CA2741767C/en active Active
- 2009-10-27 JP JP2011534678A patent/JP5775459B2/ja active Active
- 2009-10-27 EP EP15175938.8A patent/EP2963006B1/en active Active
- 2009-10-27 PL PL09824070T patent/PL2362875T3/pl unknown
- 2009-10-27 MY MYPI2014003438A patent/MY185183A/en unknown
- 2009-10-27 EP EP09824070.8A patent/EP2362875B1/en active Active
- 2009-10-27 EA EA201100699A patent/EA026417B1/ru not_active IP Right Cessation
- 2009-10-27 PT PT98240708T patent/PT2362875E/pt unknown
- 2009-10-27 HU HUE15175938A patent/HUE041714T2/hu unknown
- 2009-10-27 MY MYPI2011001873A patent/MY157119A/en unknown
- 2009-10-27 US US12/606,923 patent/US8106223B2/en active Active
- 2009-10-27 EP EP18200523.1A patent/EP3450431B1/en active Active
- 2009-10-27 WO PCT/US2009/062212 patent/WO2010051277A1/en active Application Filing
- 2009-10-27 ES ES15175938T patent/ES2701260T3/es active Active
- 2009-10-27 PT PT15175938T patent/PT2963006T/pt unknown
- 2009-10-27 EA EA201692046A patent/EA201692046A1/ru unknown
- 2009-10-27 CA CA2974482A patent/CA2974482C/en active Active
- 2009-10-27 DK DK09824070.8T patent/DK2362875T3/en active
- 2009-10-27 TR TR2018/19154T patent/TR201819154T4/tr unknown
- 2009-10-27 MX MX2011004440A patent/MX2011004440A/es active IP Right Grant
- 2009-10-27 CN CN201610142967.2A patent/CN105753829B/zh active Active
- 2009-10-27 BR BRPI0920414-8A patent/BRPI0920414B1/pt active IP Right Grant
- 2009-10-27 ES ES09824070.8T patent/ES2553557T3/es active Active
-
2012
- 2012-01-25 US US13/358,451 patent/US8575369B2/en active Active
- 2012-02-23 HK HK12101813.9A patent/HK1161876A1/zh unknown
-
2013
- 2013-09-26 US US14/038,675 patent/US20140221674A1/en not_active Abandoned
-
2014
- 2014-09-02 JP JP2014177733A patent/JP6001025B2/ja active Active
-
2015
- 2015-07-14 JP JP2015140302A patent/JP2015187169A/ja not_active Withdrawn
-
2016
- 2016-03-11 US US15/068,452 patent/US10071978B2/en active Active
- 2016-07-04 HK HK16107746.4A patent/HK1219718A1/zh unknown
-
2018
- 2018-06-06 JP JP2018108448A patent/JP7181708B2/ja active Active
- 2018-09-10 US US16/127,102 patent/US11312697B2/en active Active
-
2019
- 2019-01-22 JP JP2019008496A patent/JP2019065041A/ja not_active Withdrawn
-
2021
- 2021-02-04 JP JP2021016310A patent/JP2021066745A/ja not_active Withdrawn
-
2022
- 2022-03-18 US US17/699,061 patent/US20220204469A1/en active Pending
-
2023
- 2023-03-31 JP JP2023057343A patent/JP2023073469A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220204469A1 (en) | Process for the production of alpha-tocotrienol and derivatives | |
WO2012154613A1 (en) | Improved process for the preparation of d-alpha-tocotrienol from natural extracts | |
US20080039638A1 (en) | Asymmetric Hydrogenation of Alkennes Using Chiral Iridium Complexes | |
EP2535323A1 (en) | Hydrogenation of ketones having at least a carbon-carbon double bond in the gamma-,delta-position | |
EP0735033B1 (de) | Aminomethylierung von Tocopherolen | |
EA040327B1 (ru) | Способ получения альфа-токотриенола и его производных | |
EP4081212A1 (en) | Methods of synthesizing high-purity cannabicyclol and artificial resins comprising cannabicyclol |